Acutus Medical, Inc (AFIB)

Etorro trading 970x250
Acutus Medical, Inc (AFIB) Logo

About Acutus Medical, Inc

Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is based in Carlsbad, California. Address: 2210 Faraday Avenue, Carlsbad, CA, United States, 92008

Acutus Medical, Inc News and around…

Latest news about Acutus Medical, Inc (AFIB) common stock and company :

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
12 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
08 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
07 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Analysts Anticipate VTWG Will Reach $268
05 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Russell 2000 Growth ETF (VTWG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $268.37 per unit.

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Acutus Medical's Return On Capital Employed Overview
30 Sep, 2021 FinancialContent

According to Benzinga Pro data, during Q2, Acutus Medical (NASDAQ:AFIB) posted sales of $4.71 million. Earnings were up 1.91%, but ...

Acutus Medical, Inc. (AFIB) Moves 9.6% Higher: Will This Strength Last?
28 Sep, 2021 Yahoo! Finance

Acutus Medical, Inc. (AFIB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
28 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
23 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
22 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
21 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
16 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Relative Strength Alert For Acutus Medical
13 Aug, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Acutus Medical, Inc. (AFIB) Q2 2021 Earnings Call Transcript
13 Aug, 2021 FinancialContent

AFIB earnings call for the period ending June 30, 2021.

Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates
12 Aug, 2021 Yahoo! Finance

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of 11.00% and 1.27%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Acutus Medical Appoints Niamh Pellegrini to Board of Directors
12 Aug, 2021 FinancialContent
Acutus Medical Reports Second Quarter 2021 Financial Results
12 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
12 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark
11 Aug, 2021 FinancialContent

Enhanced Software Automatically Identifies Regions of Interest During the Treatment of Complex Atrial Arrhythmias

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
08 Aug, 2021 FinancialContent

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader ...

Acutus Medical to Participate at the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
03 Aug, 2021 FinancialContent
Acutus Medical to Announce Second Quarter 2021 Financial Results
29 Jul, 2021 FinancialContent
HRS 2021: EP Experts to Demonstrate the Benefits of Acutus Medical’s Complete Suite of EP Technologies
28 Jul, 2021 FinancialContent

Company’s Innovative Portfolio Aims to Advance Treatment of Atrial & Ventricular Arrhythmias

12 Health Care Stocks Moving In Tuesday's After-Market Session
27 Jul, 2021 FinancialContent

Gainers Acutus Medical (NASDAQ:AFIB) stock increased by 9.61% to $16.3 during Tuesday's after-market session. The market value of ...

AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
27 Jul, 2021 Yahoo! Finance

AliveCor, Inc. ("AliveCor"), a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology and services, and Acutus Medical ("Acutus") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced they will collaborate to assess the integration of data collection tools across the cardiology continuum of care that could potentially advance the field of arrhythmia treatment and disease management.

Acutus Medical, Inc. Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
26 Jul, 2021 FinancialContent
The Past Week's Most Notable Insider Buys: Blackstone, Cricut, Fast Acquisition And More
25 Jul, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A leading asset manager and a special purpose acquisition companies attracted some notable insider buying last week.

61 Biggest Movers From Yesterday
23 Jul, 2021 FinancialContent

Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company ...

Acutus Medical, Inc (AFIB) is a NASDAQ Common Stock listed in , ,

970x250